Cargando...
Liraglutide-Induced Hepatotoxicity
A 52-year-old woman with a BMI of 31.2 kg/m(2) was treated with the glucagon-like peptide 1 (GLP-1) agonist liraglutide as part of her weight-reduction program. Following this, she developed an idiosyncratic drug-related liver injury (IDILI). Advances in noninvasive techniques enabled this diagnosis...
Guardado en:
| Publicado en: | Biomedicines |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911918/ https://ncbi.nlm.nih.gov/pubmed/33498980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9020106 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|